Bariatric Surgery Market Research Report: by device (surgical stapler, gastric bands, gastric balloons, adjustable gastric band, and gastric emptying systems), by type (gastric bypass and sleeve gastrectomy), by the end user - Global forecast till 2027Market InsightsMarket Research Future stated that the global bariatric surgery market is anticipated to develop at a CAGR of 6.5% between the forecast period, 2017-2023.Bariatric surgery is mainly recommended for people with a BMI of over 40.
It is applied to improve the health of obese patients, thereby decreasing the risk of severe illnesses.
In addition, the popularity of bariatric weight loss surgery in developing countries around the world is increasing, spurring market growth.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5693Market SegmentationThe global bariatric surgery market broadly bifurcated into type, device, and end-user.The global bariatric surgery market is also divided into gastric balloons, electrical stimulation systems, gastric emptying systems, surgical stapler gastric bands, and others; based on device.The type segment of the global market is divided into sleeve gastrectomy, biliopancreatic diversion with duodenal switch, adjustable gastric band, and others.The global bariatric surgery market is classified into surgical centers, hospitals & clinics, health care facilities, and others; based on end-user.Regional InsightsThe Americas are the largest bariatric surgery market and is motivated by the availability of a large number of surgical centers, a growing awareness of obesity and risk factors, and technological advances in surgery bariatric laparoscopy.
In South America, the growth of healthcare and the growing use of medical devices in various operations is driving the market.
The CDC (Centers for Disease Control and Prevention) reported that in 2014, over one-third of US adults were obese.The European bariatric surgery market is fueled by the growing number of surgical device manufacturers and distributors, the high prevalence of diabetes, and the huge public funding available for research.
Factors that contribute to the growth of the market in Germany are the concentration of the main players in the market and the focus on controlling obesity and diabetes.In the Asia Pacific, diabetes is a major chronic disease, weighing heavily on emerging economies such as China and India.